King TA - Search Results

1

The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy.

Moossdorff M, Nakhlis F, Hu J, Barry WT, Losk K, Haskett C, Smidt ML, King TA. Moossdorff M, et al. Among authors: king ta. Ann Surg Oncol. 2018 Sep;25(9):2612-2619. doi: 10.1245/s10434-018-6519-1. Epub 2018 May 31. Ann Surg Oncol. 2018. PMID: 29855827

2

A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer.

King TA, Fey JV, Van Zee KJ, Heerdt AS, Gemignani ML, Port ER, Sclafani L, Sacchini V, Petrek JA, Cody HS 3rd, Borgen PI, Montgomery LL. King TA, et al. Ann Surg Oncol. 2004 May;11(5):535-41. doi: 10.1245/ASO.2004.10.014. Ann Surg Oncol. 2004. PMID: 15123464 Clinical Trial.

3

The importance of local control in early-stage breast cancer: a historical review and a discussion of ongoing issues.

Morrogh M, Borgen PI, King TA. Morrogh M, et al. Among authors: king ta. Ann Surg Oncol. 2007 Dec;14(12):3310-20. doi: 10.1245/s10434-007-9602-6. Epub 2007 Sep 19. Ann Surg Oncol. 2007. PMID: 17882494 Review. No abstract available.

4

MRI screening in a clinic population with a family history of breast cancer.

Yu J, Park A, Morris E, Liberman L, Borgen PI, King TA. Yu J, et al. Among authors: king ta. Ann Surg Oncol. 2008 Feb;15(2):452-61. doi: 10.1245/s10434-007-9622-2. Epub 2007 Nov 17. Ann Surg Oncol. 2008. PMID: 18026801

5

Is pleomorphic lobular carcinoma really a distinct clinical entity?

Buchanan CL, Flynn LW, Murray MP, Darvishian F, Cranor ML, Fey JV, King TA, Tan LK, Sclafani LM. Buchanan CL, et al. Among authors: king ta. J Surg Oncol. 2008 Oct 1;98(5):314-7. doi: 10.1002/jso.21121. J Surg Oncol. 2008. PMID: 18668643

6

Presenting features of breast cancer differ by molecular subtype.

Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, Morrow M. Wiechmann L, et al. Ann Surg Oncol. 2009 Oct;16(10):2705-10. doi: 10.1245/s10434-009-0606-2. Epub 2009 Jul 11. Ann Surg Oncol. 2009. PMID: 19593632

7

Impact of breast density on the presenting features of malignancy.

Arora N, King TA, Jacks LM, Stempel MM, Patil S, Morris E, Morrow M. Arora N, et al. Among authors: king ta. Ann Surg Oncol. 2010 Oct;17 Suppl 3:211-8. doi: 10.1245/s10434-010-1237-3. Epub 2010 Sep 19. Ann Surg Oncol. 2010. PMID: 20853035

8

Selecting local therapy in the young breast cancer patient.

King TA. King TA. J Surg Oncol. 2011 Mar 15;103(4):330-6. doi: 10.1002/jso.21697. J Surg Oncol. 2011. PMID: 21337567 Review.

9

Occult malignancy in patients undergoing contralateral prophylactic mastectomy.

King TA, Gurevich I, Sakr R, Patil S, Stempel M, Morrow M. King TA, et al. Ann Surg. 2011 Jul;254(1):2-7. doi: 10.1097/SLA.0b013e3182125b26. Ann Surg. 2011. PMID: 21372684

10

Is there a low-grade precursor pathway in breast cancer?

King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M. King TA, et al. Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21. Ann Surg Oncol. 2012. PMID: 21935747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page